To evaluate a potential correlation between the CA XII expression and patient survival, the OC cohort was stratified by grading, histological type, tumor stage, and age (enclosing the group with the most cases for every parameter), resulting in a subgroup of 80 cases with the following properties: HGSC, FIGO III, 60–69 years old. The gene discussed is CA12; the disease is neoplasm.